Cargando…

RNAi therapeutic strategies for acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS), replacing the clinical term acute lung injury, involves serious pathophysiological lung changes that arise from a variety of pulmonary and nonpulmonary injuries and currently has no pharmacological therapeutics. RNA interference (RNAi) has the potential to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jagrosse, Melissa L., Dean, David A., Rahman, Arshad, Nilsson, Bradley L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316156/ https://www.ncbi.nlm.nih.gov/pubmed/31401266 http://dx.doi.org/10.1016/j.trsl.2019.07.011

Ejemplares similares

Acute Respiratory Distress Syndrome: Pathophysiology and Therapeutic Options
por: Pierrakos, Charalampos, et al.
Publicado: (2012)

Acute respiratory distress syndrome
por: Chen, Hsing I., et al.
Publicado: (2003)

Gene Therapy for Acute Respiratory Distress Syndrome
por: Liu, Jing, et al.
Publicado: (2022)

Respiratory drive in the acute respiratory distress syndrome: pathophysiology, monitoring, and therapeutic interventions
por: Spinelli, Elena, et al.
Publicado: (2020)

New and conventional strategies for lung recruitment in acute respiratory distress syndrome
por: Pelosi, Paolo, et al.
Publicado: (2010)

Diagnosis and management of acute respiratory distress syndrome
por: Fernando, Shannon M., et al.
Publicado: (2021)

Supramolecular Phenylalanine-Derived Hydrogels for the Sustained Release of Functional Proteins
por: Jagrosse, Melissa L., et al.
Publicado: (2023)

Acute respiratory distress syndrome
por: Confalonieri, Marco, et al.
Publicado: (2017)

Update in acute respiratory distress syndrome
por: Koh, Younsuck
Publicado: (2014)

The acute respiratory distress syndrome in 2013
por: Matthay, Michael A, et al.
Publicado: (2013)

Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
por: Aslan, Anolin, et al.
Publicado: (2021)

Reactive Oxygen Species and Strategies for Antioxidant Intervention in Acute Respiratory Distress Syndrome
por: Lim, Eun Yeong, et al.
Publicado: (2023)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Acute respiratory distress syndrome
por: Matthay, Michael A., et al.
Publicado: (2019)

The Current State of Pediatric Acute Respiratory Distress Syndrome
por: Orloff, Kirsten E., et al.
Publicado: (2019)

Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
por: Qiao, Qi, et al.
Publicado: (2021)

Application of clinical proteomics in acute respiratory distress syndrome
por: Bhargava, Maneesh, et al.
Publicado: (2014)

Pharmacological interventions in acute respiratory distress syndrome
por: Roch, Antoine, et al.
Publicado: (2013)

Mechanical ventilation of acute respiratory distress syndrome
por: Ochiai, Ryoichi
Publicado: (2015)

Prognostic factors in the acute respiratory distress syndrome
por: Chen, Wei, et al.
Publicado: (2015)

Pathophysiology and biomarkers of acute respiratory distress syndrome
por: Fujishima, Seitaro
Publicado: (2014)

Antiplatelet Therapy for Acute Respiratory Distress Syndrome
por: Chen, Chuan-Mu, et al.
Publicado: (2020)

Endothelial Damage in Acute Respiratory Distress Syndrome
por: Vassiliou, Alice G., et al.
Publicado: (2020)

Genetic Determinants of the Acute Respiratory Distress Syndrome
por: Suarez-Pajes, Eva, et al.
Publicado: (2023)

Oxygenation target in acute respiratory distress syndrome
por: Capellier, Gilles, et al.
Publicado: (2023)

Exploring m6A‐RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome
por: Faraj, Reem, et al.
Publicado: (2023)

Using Dictyostelium to Develop Therapeutics for Acute Respiratory Distress Syndrome
por: Kirolos, Sara A., et al.
Publicado: (2021)

Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)

Editorial: Acute respiratory distress syndrome: Lung protective strategy
por: Pan, Chun, et al.
Publicado: (2023)

Guideline-based management of acute respiratory failure and acute respiratory distress syndrome
por: Fujishima, Seitaro
Publicado: (2023)

Isolated Lung Perfusion in the Management of Acute Respiratory Distress Syndrome
por: Haywood, Nathan, et al.
Publicado: (2020)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Acute Respiratory Distress Syndrome: An Update and Review
por: Rawal, Gautam, et al.
Publicado: (2018)

Nanotherapeutics in the treatment of acute respiratory distress syndrome
por: Prasanna, Pragya, et al.
Publicado: (2021)

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
por: Freitag, Julien, et al.
Publicado: (2020)

Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment—From Mice to Men
por: von Knethen, Andreas, et al.
Publicado: (2022)

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges
por: Cao, Chao, et al.
Publicado: (2022)

Systematic review of diagnostic methods for acute respiratory distress syndrome
por: Hagens, Laura A., et al.
Publicado: (2021)

COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review)
por: Krynytska, Inna, et al.
Publicado: (2021)

Extracorporeal life support for adults with acute respiratory distress syndrome
por: Combes, Alain, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8e7o0fti989imkgb7rq895moms